Abstract

<h3>Objective.</h3> —To characterize the natural history of viremia with human immunodeficiency virus type 1 (HIV-1) and its association with disease progression from infection to acquired immunodeficiency syndrome (AIDS). <h3>Design.</h3> —Prospective cohort study. Annual specimens were tested for quantitative virion-associated HIV-1 RNA, p24 antigen, and CD4<sup>+</sup>lymphocyte levels. <h3>Participants.</h3> —A total of 42 homosexual men who seroconverted to HIV-1 between 1982 and 1985. <h3>Main Outcome Measures.</h3> —Trends over time in serum HIV-1 RNA level, correlations between serum HIV-1 RNA and other markers, and prediction of AIDS using these markers. <h3>Results.</h3> —HIV-1 RNA levels were stable overtime, increasing by 10-fold or more in only six (14%) of the 42 subjects during 3 to 11 years of follow-up. Mean HIV-1 RNA levels were 10<sup>3.8</sup>copies/mL if AIDS occurred in less than 4 years, 10<sup>3.07</sup>copies/mL if AIDS developed within 4 through 9 years, and 10<sup>2.27</sup>copies/mL if AIDS did not develop within 6 through 11 years. In both univariate and multivariate models, initial and subsequent HIV-1 RNA levels, p24 antigenemia, and percentage of CD4<sup>+</sup>lymphocytes were independently predictive of AIDS. <h3>Conclusions.</h3> —The stability of virion-associated HIV-1 RNA levels suggests that an equilibrium between HIV-1 replication rate and efficacy of immunologic response is established shortly after infection and persists throughout the asymptomatic period of the disease. Thus, defective immunologic control of HIV-1 infection may be as important as the viral replication rate for determining AIDS-free survival. Because individual steady-state levels of viremia were established soon after infection, HIV-1 RNA levels may be useful markers for predicting clinical outcome. (<i>JAMA</i>. 1995;274:554-558)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call